Acute Treatment of Migraine with Celecoxib Oral Solution: Results of a Randomized, Placebo-Controlled Clinical Trial.

Richard B LiptonSagar MunjalDavid W DodickStewart J TepperDaniel SerranoCharlie Iaconangelo

Published in: Journal of pain research (2021)

DFN-15 was superior to placebo for pain freedom and freedom from the most bothersome symptom when patients treat a migraine attack of any baseline pain intensity. Rates of TEAEs did not differ between treatment groups.

Keyphrases

clinical trial
chronic pain
double blind
end stage renal disease
pain management
placebo controlled
neuropathic pain
newly diagnosed
ejection fraction
chronic kidney disease
phase ii
combination therapy
open label
drug induced
rectal cancer
aortic dissection
locally advanced
solid state